D. E. Shaw & Co., Inc.

Position in IMCR — Immunocore Holdings plc

CIK 1009207 New York, NY

Position in IMCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,106,008

+$3,721,451 QoQ

Shares Held

335,191

+82.2% QoQ

Ownership

0.659%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. IMCR ranks #62 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,625,825	$919,934,903
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,059,062	$350,411,843
3	BBIO	BridgeBio Pharma, Inc.	2,545,486	$189,027,789
4	PCVX	Vaxcyte, Inc.	2,865,318	$166,503,628
5	EXEL	Exelixis, Inc.	3,603,063	$154,535,371
6	HALO	Halozyme Therapeutics, Inc.	1,868,708	$120,774,597
7	PTCT	Ptc Therapeutics, Inc.	1,640,381	$111,759,157
8	VRTX	Vertex Pharmaceuticals Inc / Ma	248,960	$111,170,598

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,106,008	335,191	+82.2%	Shares	Defined	2026-05-15
2025-12-31	$6,384,557	183,940	+842.6%	Shares	Defined	2026-02-17
2024-06-30	$661,363	19,515	-86.1%	Shares	Defined	2024-08-14
2024-03-31	$9,106,110	140,094	+65.5%	Shares	Defined	2024-05-15
2023-12-31	$5,783,492	84,653	-38.8%	Shares	Defined	2024-02-14
2023-09-30	$7,183,115	138,403	-37.1%	Shares	Defined	2023-11-14
2023-06-30	$13,188,741	219,959	-30.0%	Shares	Defined	2023-08-14
2023-03-31	$15,545,864	314,439	-13.5%	Shares	Defined	2023-05-15
2022-12-31	$20,739,180	363,399	+174.3%	Shares	Defined	2023-02-14
2022-09-30	$6,219,643	132,502	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.